Physician profile
Mason Thomas Bates
NPI 1255907515
$7,537.17
in general payments reported to CMS, 2019-2025
8 companies · $5,290 in 2025
The $5,290 reported for 2025 was more than what 98% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,472 · 2022: $75.28 · 2023: $604 · 2024: $95.03 · 2025: $5,290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $5,210 · Food and Beverage: $780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $5,210.00 |
| Food and Beverage | $779.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $6,828.19 | 2021-2025 | Invisalign, Invisalign System - Moderate, Invisalign First - Comprehensive |
| Ormco Corporation | $280.76 | 2021-2023 | Spark, Miniendo II |
| Nobel Biocare USA | $226.79 | 2023 | Nobelactive |
| Lightforce Orthodontics, INC. | $84.96 | 2023 | |
| Solventum Corporation | $41.26 | 2024-2025 | Clarity Aligners, Apc Flash-Free Clarity Advanced, Apc Flash-Free Victory Series Low Profile |
| 3m Company | $36.05 | 2021 | |
| World Class Technology Corporation | $26.02 | 2022 | |
| American Orthodontics Corporation | $13.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mason Bates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.